A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis

Journal of Gastroenterology

Volumn 44, Issue 6, 2009, Pages 615-623

  Yamagishi, Yoshiyuki ^a   Saito, Hidetsugu ^a   Ebinuma, Hirotoshi ^a   Kikuchi, Masahiro ^a   Ojiro, Keisuke ^a   Kanamori, Hideaki ^a   Tada, Shinichiro ^a   Horie, Yoshinori ^a   Kato, Shinzo ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Computed tomography derived liver volume standardized liver volume ratio (CTLV SLV); King's College Hospital (KCH) criteria; Liver atrophy; Living donor liver transplantation (LDLT); Model for end stage liver disease (MELD)

Indexed keywords

BILIRUBIN; ENTECAVIR; INTERFERON; LAMIVUDINE; STEROID;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATOGRAPHY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; BILIRUBIN; FEMALE; HUMANS; LIVER; LIVER FAILURE, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 67449105521     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0045-7     Document Type: Article

References (33)

1. Miwa S, Hashikura Y, Mita A, Kubota T, Chisuwa H, Nakazawa Y, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology. 1999;30:1521-6.
2. Uemoto S, Inomata Y, Sakurai T, Egawa H, Fujita S, Kiuchi T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70:152-7.
3. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20:1169-72.
4. Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G, et al. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008;38:646-57.
5. Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, et al. Outcomes of adult-to-adult living donor liver transplantation: A single institution's experience with 335 consecutive cases. Ann Surg. 2007;245:315-25.
6. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49-53.
7. Nunez-Martinez O, De la Cruz G, De Diego A, Molina J, Rincon D, Santos L, et al. Liver transplantation for fulminant and subfulminant hepatic failure. Transplant Proc. 2003;35:1855-6.
8. Sugawara Y, Kaneko J, Imamura H, Minagawa M, Kokudo N, Makuuchi M. Living donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2002;34:3287-8.
9. The Japanese Liver Transplantation Society. Liver transplantation in Japan. Ishoku. 2007;41:599-608. (in Japanese).
10. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl. 2004;10:886-97.
11. Yamagishi Y, Saito H, Shimadu M, Hoshino K, Kobayashi H, Nakamoto N, et al. Intensive therapy for fulminant hepatic failure: Importance of co-operation between physicians of internal medicine and transplantation surgery. Nippon Shokakibyo Gakkai Zasshi. 2002;99:1205-12. (in Japanese).
12. Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004;36:2355-6.
13. Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: A single-center experience. Dig Dis Sci. 2006;51:47-53.
14. Camus C, Lavoue S, Gacouin A, Le Tulzo Y, Lorho R, Boudjema K, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med. 2006;32:1817-25.
15. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439-45.
16. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis. 1986;6:129-37.
17. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-70.
18. Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764-9.
19. Sekiyama K, Yoshiba M, Inoue K, Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci. 1994;39:240-4.
20. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317-21.
21. Yamagishi Y, Saito H, Tada S, Horie Y, Kato S, Ishii H, et al. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol. 2005;20:1843-9.
22. Suzuki H. Hepatitis A, fulminant hepatitis. In: 12th Inuyama symposium reports. Tokyo: Chugai Igakusya; 1982. p. 110-230 (in Japanese).
23. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-15.
24. Sugihara J, Naito T, Ishiki Y, Murakami H, Uchimoto T, Koshino Y, et al. A multicenter study on the prognosis and indications of liver transplantation for fulminant hepatitis in Japan. Acta Hepatol Jpn. 2001;42:543-57. (in Japanese).
25. Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90:185-7.
26. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int. 2007;27:329-34.
27. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl. 2007;13:814-21.
28. Nitta M, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, et al. Long-term survivors with artificial liver support in fulminant hepatic failure. Ther Apher. 2002;6:208-12.
29. Marcos A, Ham JM, Fisher RA, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;69:2202-5.
30. Abouna GJ. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure - is it justifiable? Transplantation. 2001;71:1498-500.
31. Haussinger D. Fulminant liver failure: Is living related liver transplantation justified with respect to donor risk? Transplant Proc. 2003;35:920-1.
32. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007;13:822-8.
33. Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970-9.